Dishman Carbogen Amcis Limited (NSE:DCAL)
India · Delayed Price · Currency is INR 167.50
+0.01 (0.01%)
Sep 11, 2026, 3:29 PM IST
Dishman Carbogen Amcis Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 26.22 billion as of September 14, 2026. Its market cap has decreased by -38.45% in one year.
Market Cap
26.22B
Enterprise Value
46.91B
Revenue
29.01B
Ranking
n/a
PE Ratio
162.08
Stock Price
167.50
ChartMarket Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 26.22B, a decrease of -53.85%. That is a compound annual growth rate of -8.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 26.22B | -32.45% |
| Dec 31, 2025 | 38.82B | -8.46% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 632.66B |
| Anthem Biosciences | 529.91B |
| OneSource Specialty Pharma | 182.54B |
| Concord Biotech | 157.52B |
| Blue Jet Healthcare | 107.61B |
| Supriya Lifescience | 72.58B |
| Zota Health Care | 37.65B |
| Panacea Biotec | 24.36B |